ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma

Condition:   EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Interventions:   Drug: Atezolizumab;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pemetrexed Sponsors:   European Thoracic Oncology Platform;   Roche Pharma AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials